Skip to main content
. 2021 Apr 6;9(4):391. doi: 10.3390/biomedicines9040391

Table 2.

Copper-dependent Enzymes and basic properties.

Enzyme OMIM EC-no. Cofactor Cu Donor Cu Loading Site Cu Chaperone Subcellular Localization ATP7A-Linked Cu Deficiency Symptoms
ATOX1 regulated
Copper Pumps
ATP7A 300011 7.2.2.8 Mg; ATP
Cu-ATOX1 allosteric
ATOX1
Cu-GSH
Cytosol ATOX1 piggy-backing SP, TGN, PM Cu storage in tissues, low in brain, liver, plasma; S-Cu diagnostic after 1.5 mo
ATP7B 606882 7.2.2.8 Mg; ATP
Cu-ATOX1 allosteric
ATOX1
Cu-GSH
Cytosol ATOX1 piggy-backing SP, TGN, secretory vesicles Low activity in brain and liver; Fe accumulation; icterus, steatosis
Copper Reductases STEAP1 604415 1.16.1.- Heme; NAD Cu-His EC redox NAp PM,
endosomes
Cu and Fe accumulation on plasma membranes and vesicles; hypochromic anemia
STEAP2 605094 1.16.1.- Heme; NAD Cu-His EC redox NAp PM, Golgi
STEAP3 609671 1.16.1.- Heme; NADP Cu-His EC redox NAp PM,
endosomes
STEAP4 611098 1.16.1.- Heme; NADPH Cu-His EC redox NAp PM, ER, Golgi
endosomes
nucleus, MIT
CYBDR 605745 1.-.-.- Heme; ascorbate Cu-His EC redox NAp PM
Copper Oxidases CP 117700 1.16.3.1 Cu; ascorbate ATP7B ERGIC NK EC CP low in plasma; diagnostic after 1½ month; Cu and Fe storage
FV+VIII 612309 300841 1.16.3.1 Cu; ascorbate ATP7B ERGIC NK EC Mild clotting deficiency
HEPH 300167 1.16.3.1 Cu; ascorbate ATP7A ERGIC NK Vesicles Cu and Fe intracellular storage; AMD
HEPH1L 618455 1.16.3.1 Cu; ascorbate ATP7A ERGIC NK cis-Golgi Cutis laxa
COX
 
CuA (II)
 
 
CuB (I)
 
 
516040
 
 
516030
1.9.3.1  
 
Cu
 
 
Cu;Heme
 
Redox
SCO1;
SCO2;
COA6
COX11
 
 
IMS
 
 
IMS
 
 
COX17
 
 
COX17
IMM Low COX in brain and liver due to low Cu availability; High lactate in blood;
Leigh-like symptoms; COX defects; ragged red fibers; hypotonia
Copper Quinone Amine Oxidases LOX 153455 1.4.3.1 Cu; LTQ ATP7A cis-Golgi HEPH1L redox EC Numerous connective tissue abnormalities: tortuous vessels, aortic aneurisms, and dissections, umbilical or inguinal hernias, bladder and bowel diverticulae, loose joint and skin, osteoporosis, lymphedema, lung infections; collectin defects with protein trafficking problems, and deficient activation of complement pathway; NAI-like; cataract
LOXL1 153456 1.4.3.1 Cu; LTQ ATP7A cis-Golgi Redox loading # EC
LOXL2 606663 1.4.3.1 Cu; LTQ ATP7A cis-Golgi Redox loading # ER, nucleus *
LOXL3 607163 1.4.3.1 Cu; LTQ ATP7A cis-Golgi Redox loading # ER, nucleus *
LOXL4 607318 1.4.3.1 Cu; LTQ ATP7A cis-Golgi Redox loading # EC
AOC1 104610 1.4.3.22 Cu; TPQ ATP7A cis-Golgi Redox loading # EC Ichthyosis, alopecia, inflammation, conjunctivitis, atopy, photophobia, keratitis, diarrhoea, gastrointestinal polyps
AOC2 602268 1.4.3.21 Cu; TPQ ATP7A cis-Golgi Redox loading # PM
AOC3 603735 1.4.3.21 Cu; TPQ ATP7A cis-Golgi Redox loading # PM
FGly
Generation
SUMF1 607939 1.8.3.7 Cu; Ca ATP7A ER SUMF2 SP GAG accumulation in tissues and urine; metachromasia, Alder Reilly anomaly; overlapping clinical features of multiple sulfatase deficiency (MSD) mimicking metachromatic leukodystrophy,
mucopolysaccharidosis (MPS), mucolipidosis (MLP), chondrodysplasia punctata, hydrocephalus
FGly
Activated Sulfatases
ARSA 607574 3.1.6.8 FGly; Ca NAp NAp NAp Lysosomes
ARSB 611542 3.1.6.12 FGly; Ca NAp NAp NAp Lysosomes
ARSD 300002 3.1.6.- FGly; Ca NAp NAp NAp Lysosomes
ARSF 300003 3.1.6.- FGly; Ca NAp NAp NAp EC
ARSE 300180 3.1.6.- FGly; Ca NAp NAp NAp Golgi
ARSG 610008 3.1.6.1 FGly; Ca NAp NAp NAp Lysosomes
ARSH 300586 3.1.6.- FGly; Ca NAp NAp NAp PM
ARSI 610009 3.1.6.- FGly; Ca NAp NAp NAp EC
ARSJ 610010 3.1.6.- FGly; Ca NAp NAp NAp EC
ARSK 610011 3.1.6.- FGly; Ca NAp NAp NAp EC
GALNS 612222 3.1.6.4 FGly; Ca NAp NAp NAp Lysosomes
GNS 607664 3.1.6.14 FGly; Ca NAp NAp NAp Lysosomes
IDS 300823 3.1.6.13 FGly; Ca NAp NAp NAp Lysosomes
STS 300747 3.1.6.2 FGly; Ca NAp NAp NAp ER ichthyosis, seborrhoea, hair changes
Copper Amine Oxidases DBH 609312 1.14.17.1 Cu; ascorbate ATP7A ER MOXD1# Vesicles; EC High DA/NE; vomiting, hypotension, hypothermia, hypoglycemia
PAM
PHM
PAL
170270  
1.14.17.3
4.3.2.5
Cu; ascorbate
Zn; Ca
 
ATP7A
NAp
 
TGN
NAp
 
NK
NAp
Golgi Vesicles Pain, seizure, anxiety, impaired wakening, temperature, weight and fluid balance
TYR 606933 1.14.18.1 Cu; ascorbate ATP7A ER TYRP1
TYRP2
Melanosomes Albinism, visual and hearing problems
MOXD1 609000 1.14.17.- Cu; ascorbate ATP7A ER - ER ~DBH deficiency
Cu/Zn Superoxide Dismutases SOD1 147450 1.15.1.1 Cu; Zn
Cu-CCS
allosteric
GSH
ATP7A
matrix
NK
Cytosol
ER
IMS
NK
CCS redox and piggy-backing
CCS redox
CCS
Cytosol
peroxisomes
IMS
nucleus
Low SOD1 activity in nerve tissue and liver due to poor Cu availability; peroxisomal pathologies; motor neuron disease
SOD3 185490 1.15.1.1 Cu; Zn ATP7A SP NK EC Lung disease, angiopathy
CCS 603864 NA Cu;Zn GSH
ATP7A
matrix
nucleus
Cytosol
ER
IMS
nucleus
NAp Cytosol
peroxisomes
IMS
nucleus
Purkinje cell pathologies; ALS-like phenotype
APP 104760 NA Cu; Zn NK SP NK EC Senecense, cerebral angiopathy
APLP1 104775 NA Cu; Zn NK SP NK EC
APLP2 104776 NA Cu; Zn NK SP NK EC
Cu-CCS
Regulated Enzyme
BACE1 604252 3.4.23.46 Cu-CCS
allosteric
CCS SP CCS TGN Poor neuronal growth

#: indicated; *: histone biology; EC: extracellular; ER: endoplasmic reticulum; ERGIC: ER–Golgi intermediate compartment; GAG: glycoamino glycans; GHS: glutathione; IMM: inner mitochondrial membrane; IMS: intra mitochondrial space; MIT: mitochondria; NA: not assigned; NAI: non-accidental injuries; NAp: not applicable; NK: not known; PM: plasma membrane; SP: secretory pathway; TGN: trans-Golgi network.